BYSI Stock Analysis: Buy, Sell, or Hold?

BYSI - BeyondSpring Inc. Ordinary Shares

PHARMACEUTICAL PREPARATIONS
$1.33
-0.11 (-7.64%) β–Ό
5d: -25.7%
30d: -19.39%
90d: -23.56%
WAIT
LOW Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 12, 2026 29d

Get Alerted When BYSI Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

πŸ’‘
Bottom Line:
⏸️ WAIT FOR STABILIZATION: BYSI is down 25.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
See Forward Earnings Fair Value & Price Prediction β†’

In-depth Analysis How we analyze

Valuation Analysis: BYSI is currently trading at $1.33, which is considered oversold relative to its 30-day fair value range of $1.54 to $1.77.

Technical Outlook: Technically, BYSI is in a uptrend. Immediate support is located at $1.29, while resistance sits at $1.92. Short-term momentum is weak, with the stock down 7.6% recently.

Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position OVERSOLD
Historical Trading Range $1.54 - $1.77
Company Quality Score 55/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 69.5%

All Signals

  • BULLISH: Price oversold vs 30-day range
  • NEUTRAL: Mixed technical signals (40/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-7.6%)
  • BEARISH: Trading above Wall St target ($1.25)
  • WARNING: Recommendation downgraded due to -25.7% 5-day decline - wait for stabilization

Trading Range Analysis

30-Day Trading Range $1.54 - $1.77
Current vs Trading Range OVERSOLD

Support & Resistance Levels

Support Level $1.29
Resistance Level $1.92
Current Trend Uptrend
Technical data as of Jul 13, 2026

Fundamental Context

Forward P/E (Next Year Est.) 10.54
Wall Street Target $1.25 (-6.0%)
Revenue Growth (YoY) 14.3%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: July 13, 2026 6:01 PM ET
Data refreshes hourly during market hours. Next update: 7:01 PM
πŸ”₯ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for BYSI.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ALNY
Alnylam Pharmaceuticals …
STRONG BUY
30 analysts
$441 60 HOLD
RARE
Ultragenyx
STRONG BUY
20 analysts
$52 62 BUY
BBIO
BridgeBio Pharma Inc
STRONG BUY
19 analysts
$102 67 BUY
NRIX
Nurix TherapeuticsΒ Inc
STRONG BUY
18 analysts
$32 61 BUY
BHVN
Biohaven Ltd.
STRONG BUY
16 analysts
$22 59 HOLD

More Analysis for BYSI

BYSI Technical Chart BYSI Price Prediction BYSI Earnings Date BYSI Investment Advisor BYSI Fair Price Analyzer BYSI Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals